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Gerbera hybrida on asteraceae-heimon kasvi, jota on ehdotettu uudeksi mallilajiksi kehi-
tysbiologian tutkimuksissa. Muita tunnettuja mallilajeja ovat esimerkiksi banaanikärpänen 
ja Escherichia coli-bakteeri. Kukkakasveista on toistaiseksi vain yksi hyvin tunnettu malli-
laji, Arabidobsis thaliana. 
 
Yksi mielenkiintoinen piirre on Gerberan sekundaariset metaboliatuotteet, erityisesti gerbe-
riini ja parasorbosidi. Näiden metaboliatuotteiden tiedetään toimivan Gerberan puolustus-
mekanismissa taudinaiheuttajia ja kasvissyöjiä vastaan. 
 
Tämän työn tarkoituksena oli ilmentää ja puhdistaa Gerbera hybridan entsyymejä E. coli -
kannassa Lemo 21. Näiden entsyymien tiedetään tai niiden ehdotetaan toimivan gerberii-
nin ja parasorbosidin biosynteeseissä. Nämä entsyymit ovat G2PS1, G2PS2, PKS8 (ger-
beran polyketidit, ~45 kDa), GTKPR1, GRED1 ja GRED2 (gerberan reduktaasit, ~35 kDa). 
Nämä ovat toistaiseksi heikosti tunnettuja entsyymejä ja niitä ei olla tutkittu missään muu-
alla. 
 
Heterologinen ekspressio aloitettiin viljelemällä valmiita ekspressio-isäntäkonstrukteja. 
Isännät oli transformoitu aikaisemmin pHis8:lla, joka on muunneltu pET-28-vektori. Se si-
sälsi geenin, joka tarvitaan entsyymien ilmentämiseen multikloonauskohdassa. Ekspres-
soitujen proteiinien N-terminuksessa oli 8x-histidiinihäntä, jota hyödynnettiin tuotteen puh-
distamiseen ja tunnistamiseen. Isäntäsolut lysaattiin ja ekspressoidut entsyymit puhdistet-
tiin His SpinTrap -kitillä. Puhdistusvaiheiden fraktiot kerättiin ja analysoitiin Bradford-määri-
tyksellä. Fraktiot analysoitiin lisäksi SDS-PAGE- ja dot blot -menetelmillä tuotteen koon ja 
histidiinihännän läsnäolon määrittämiseksi. 
 
Havaittiin, että GRED1 ja GRED2 eivät tuottaneet yhtä vahvaa signaalia dot blot -menetel-
mällä, kuin muut entsyymit. Tämä saattoi johtua proteiinin väärästä laskostumisesta jo eks-
pressiovaiheessa, jolloin se ei eluoitunut halutussa vaiheessa. Niiden ekspressio kuitenkin 
tuotti runsaasti tuotetta ja GRED1:n saantoa saatiin lisättyä 51,45 % muokkaamalla eks-
pressio- ja puhdistusmenetelmiä. Kaikki tuotetut entsyymit varastoitiin jatkotutkimuksia var-
ten. 
Avainsanat Proteiiniekspressio, biosynteesi, metaboliatuotteet, entsyymit 
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Gerbera hybrida is a plant in the asteraceae family that has been proposed as a new 
model species for development biology studies. Other well-known model species include 
the fruit fly and Escherichia coli, for example. Of flowering plants there is only one well 
known model species so far, Arabidobsis thaliana.  
 
One feature of interest is Gerberas secondary metabolite pathways, notably gerberin, par-
asorboside. Gerberin and parasorboside are known to function in the defense mechanism 
of Gerbera against pathogens and herbivores. 
 
The aim of this work was to express and purify a set of enzymes of Gerbera hybrida in 
Escherichia coli strain Lemo 21. These enzymes are known or are proposed to function in 
the biosynthesis of gerberin and parasorboside. These enzymes are G2PS1, G2PS2, 
PKS8 (gerbera polyketides, ~45 kDa), GTKPR1, GRED1 and GRED2 (gerbera reduc-
tases, ~35 kDa). These enzymes are still not very well known, and they have not been 
used in research anywhere else. 
 
The heterologous exspression was begun by culturing the expression host constructs that 
had been provided. The hosts were previously transformed with pHis8, a pET-28 vector 
that included the gene necessary for the expression of the enzymes in the multicloning 
site. The expressed proteins had an 8x histidine tag to the N-terminus which was used to 
purify and identify the product. The host cells were lysated and the expressed enzymes 
purified with His SpinTrap kit. The fractions of the purification steps were collected and an-
alyzed with Bradford assay. The fractions were additionally analyzed with SDS-PAGE and 
dot blot methods to determine the product size and the presence of the 8x histidine tag re-
spectively.  
 
It was discovered that GRED1 and GRED2 did not produce as strong a signal in the dot 
blot analysis as the other enzymes. This might have been due to incorrect folding of the 
protein where the histidine tag was folded inside the protein structure and thus was not pu-
rified in the correct fraction and did not produce a strong signal in dot blot. The expression 
and purification methods were modified and the yield of GRED1 was increased by 51.45 
%. All the expressed enzymes were stored for further study. 
Keywords Protein expression, biosynthesis, metabolites, enzymes 
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Abbreviations 
G2PS1, G2PS2 Gerbera 2-pyrone synthases  
GTKPR1 Gerbera tetraketide α-pyrone reductase, specific to the an-
ther region of Gerbera 
GRED1, GRED2 Similar to GTKPR1, but found in other regions of the plant as 
well 
HPLC  High-performance liquid chromatography 
PKS8  Polyketide synthase 
SDS-PAGE  Sodium dodecyl sulfate–polyacrylamide gel electrophoresis  
TLC  Thin-layer chromatography 
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1 Introduction 
This work was conducted at the Faculty of Agriculture and Forestry, University of Hel-
sinki. The “Gerbera Lab” research group focuses on Asteraceae developmental biology 
and secondary metabolism. The group has studied the model plant Gerbera hybrida for 
decades and has published numerous papers in the field of plant biology and biotech-
nology. This subject was chosen because of the author’s interest in biology and biochem-
istry. 
Gerbera hybrida is a relatively new model organism in plant biology. It belongs to the 
large Asteraceae (alternatively Compositae) family, also known as the sunflower, or 
daisy family, which consist of around 25 000 species. It is well known as ornamental crop 
around the world and grown in the tens of millions annually. 60 million plants are grown 
in California alone and over 100 million in Europe each year. The economic importance 
of the plant is therefore significant. [1.] 
G. hybrida shows a wide range of morphological variations, useful for developmental, 
evolutionary and genetic reseach. It also produces a wide range of the secondary me-
tabolites, some of them only found in the Asteraceae family. These traits make it an 
excellent model plant of its family. [1; 2]. 
The aim of this work was to express and purify key enzymes in the biosynthetic pathways 
of Gerbera. These enzymes work in conjunction to produce secondary metabolites that 
have a significant role in the defense mechanism of Gerbera against fungal and bacterial 
infections. Knowledge of this pathway may have significant applications in the future, in 
farming for example. Detailed knowledge of the metabolic pathways mentioned provides 
tools to modify them in other plant species also. Transforming a plant with a gene that 
provides a resistance to infections or from herbivore attack would reduce or remove com-
pletely the need for herbicides in the future.  
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2 Asteraceae and Gerbera hybrida 
Asteracea is a large family that includes many commonly known edible, herbal and or-
namental plant genuses such as sunflower, lettuce, artichoke, chrysanthemum, aster 
and of course the genus Gerbera. Asteraceae is thought to originate from the area 
around modern Patagonia, Argentina when the continents of South America and Africa 
were still connected. Since then members of the family have spread to all parts of the 
globe except Antarctica. 
A common feature among all Asteraceae species is the inflorescence that resembles a 
single flower but is rather a dense structure of multiple smaller, specialized flowers. This 
feature is believed to be a key factor for the success of Asteracae Moreover Asteraceae 
species show wide range of colors and shapes attracting pollinators and humans alike.  
The genus Gerbera, sometimes called the African daisy, includes around 30 species that 
grow in southern Africa, Madagascar and the tropical regions of Asia. Economically and 
scientifically the most important is a hybrid cultivar of two South African species, Gerbera 
jamesonii and Gerbera viridifolia called Gerbera hybrida (figure 1). [2; 3.] 
Figure 1. G. jamesonii (left) [4] and G. viridifolia (right) [5] 
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G. hybrida has three specialized flower types in its inflorescence: colorful “ray” flowers in 
the outermost form the most visible part or the plant with their elongated petals (figure 
2). The middle part consists of central “disc” flowers that have very small petals. Between 
the ray and disc are so-called “trans” flowers that are similar to ray flowers but have 
shorter petals. [6.] Ray and trans-flowers are female, while disc flowers are both female 
and male [2]. 
Figure 2. Comparison of the inflorescense of sunflower (Helianthus annuus) and 
G. hybrida. Note how the sunflower lacks trans-flowers. [6] 
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3 Polyketide Biosynthetic Pathways in Gerbera 
3.1 Secondaty Metabolites  
Secondary metabolites are as their name suggest, secondary in importance for the basic 
biomechanical processes of a plant. Secondary metabolites are a diverse group of low-
molecular weight compounds that are important in mechanisms such as defense against 
pathogens and herbivores, floral scent, pigments for attracting pollinators or preventing 
water loss during drought. Therefore, they are not directly important for the growth and 
life of the plant but are necessary when interacting with external factors. Without them 
an organism would not thrive in nature. [7.] 
Prasorboside and gerberin are two very similar compounds involved in the defense 
against plant pathogens. In addition, parasorboside is regarded as a precursor to para-
sorbic acid which in turn is related to sorbic acid, a common food preservative. It is pre-
sent also in other plants, such as the berries of Sorbus aucuparia, where the compound 
got its name. [7; 8.] The proposed biosynthetic pathway is presented in figure 3. Note 
that this is a proposition based on current knowledge and it may change in the future. 
Figure 3. Proposed biosynthetic pathways of gerberin and parasorboside. The first stages are catalyzed by 2-
pyrone synthase G2PS1 and the aglycones are thought to be catalyzed by reductase enzymes (PKR, GRED1 and 
GRED2). Glucosyltransferases (GluT) attach a glucose to the aglycones to form gerberin and parasorboside. Upon 
infection, β-glucosidase removes the glucose to convert them back to bioactive aglycone forms. [9] 
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Gerberin and parasorboside are synthesized in a storage form and are not bioactive until 
they are needed. It is anticipated that once an attack by pathogens occurs, the glucose 
is separated from the compounds by β-glucosidase and they become bioactive as seen 
in figure 3. [7; 9.] These aglycone forms of gerberin and parasorboside are classified as 
phytoalexins, meaning that they are not detectable unless the plant is infected by path-
ogens. Phytoanticipins on the other hand are antipathogenic agents that are synthesized 
throughout the growth and development of the plant. [7.] 
Sporopollenin forms the outer shell of pollen called exine. It is a biopolymer structure that 
surrounds the inner layers. Sporopollenin protects pollen from pathogens, UV radiation, 
and dehydration and interacts with female reproductive cells during pollination. Its path-
way has been identified in Arabidobsis thaliana and Gerbera is thought to have similar 
pathway and enzymes (figure 4). [10; 11.] 
3.2 Polyketide and reductase enzymes 
It has been discovered in a previous study that without the ability to express G2PS1 
(Gerbera 2-pyrone synthase) enzyme, Gerbera is unable to produce gerberin and para-
sorboside and therefore cannot resist fungal infection effectively [7].  
Polyketide synthases are a large group of enzymes present in plants, fungi, bacteria and 
some animals. Their purpose is to synthesize secondary metabolites from precursor mol-
ecules. Many secondary metabolites synthesized by polyketides are toxic to micro-or-
ganisms. Polyketide synthases are used in pharmacological industry to produce antibi-
otics, for example. Polyketides form the first part in gerberin and parasorboside biosyn-
thesis in Gerbera. 
Figure 4. Proposed biosynthetic pathway of Hydroxy alkyl α-pyrone, a sporopollenin precursor. In A. thaliana 
the functioning enzymes are APKSB, ATKPR1 and ATKPR2 [11].  
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Reductase enzymes catalyse biochemical reduction reactions by lowering the energy 
needed for electron gain for target molecules. In Gerbera the reductases GRED1 and 
GRED2 catalyse the final steps in gerberin and parasorboside biosynthesis. GRED1 and 
GRED2 are two novel enzymes similar to tetraketide α-pyrone reductase 2 (TKPR2), 
which is specific to the anther region of Gerbera. TKPR2 is itself similar to GTKPR1. 
GRED1 and GRED2 are thought to function in the sporopollenin biosynthetic pathway 
as well as the biosynthetic pathways of gerberin and parasorboside. They are expressed 
in many tissues of Gerbera, not just the anther region and their genes are co-expressed 
with that of G2PS1.  
Overall aim of the expression and purification of these enzymes was to conduct an in 
vitro enzymatic assay. In the assay G2PS1 will be provided with malonyl-CoA and acetyl-
CoA to provide substrate for GRED1 and GRED2. The end products will be analysed 
with GC-MS. Furthermore, the enzymes will be used in pollen grain viability tests to study 
the development of pollen grains. 
4 Protein Expression  
4.1 Expression Host 
Lemo 21 is an E. coli strain that is widely used in protein expression. Lemo 21 is a ver-
satile T7 polymerase-based strain that has a resistance to chloramphenicol. This strain 
can be used to create protein expression constructs by transforming them with a vector 
that contains a T7 promoter, such as pET-28. [13.] 
PHis8 is a slightly modified pET-28 vector. It contains T7 promoter and therefore is com-
patible with Lemo 21 that expresses the T7 polymerase. It also has a kanamycin re-
sistance for selective growth and contains a multicloning that is used to integrate the 
protein encoding sequence for expression. Expressed protein receive an 8x histidine tag 
in the N-terminus that is applied for identification throughout the process. [13.] The ex-
pression, under control of the lac operon can be induced by adding isopropyl β-d-1-thio-
galactopyranoside (IPTG) to the growth culture. IPTG mimics the substrate of lacI re-
pressor, which is bound to the lac operon. The repressor, however, cannot digest the 
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substrate and remains inactive. The RNA polymerase is then able to start gene transcrip-
tion. [14.]  
4.2 Purification method 
His SpinTrap column is optimized for histidine-tagged protein purification and contains 
nickel ions (Ni2+) in a polyethylene frit. In principle, it is an immobilized metal ion affinity 
chromatography (IMAC) column in which the histidine-tagged target proteins are bound 
by the column matrix. All other biomolecules without any affinity towards the matrix flow 
through the column after which the target protein may be eluted with elution buffer. The 
elution buffer has a stronger affinity towards the matrix and knocks the target proteins 
into the elution buffer. [15.] 
4.3 Dot Blotting 
Dot blotting is a detection method for proteins in which a primary and secondary antibody 
is bound to a protein sample. It is a simplified version of Dot blotting, where the proteins 
are not separated with electrophoresis. The protein themselves are blotted on a nitrocel-
lulose membrane that is blocked to ensure that the antibodies only bind to the intended 
targets and not the membrane. The antibodies mark the target protein, so it can be de-
tected from a solution containing other proteins and biomolecules. These antibodies are 
usually specific to the target protein or a group of proteins. 
The primary antibody binds to the target site in the protein and the secondary antibody 
binds only to the primary antibody. After binding, a detection reagent is used to visually 
identify the secondary antibody. This reaction can be for example formation of colour or 
luminescence. Excess antibodies are washed from the membrane. [16.] 
5 Methods 
All the reagents and solutions used in this work are listed in the appendix sections 1 and 
2. 
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5.1 Expression Culture 
A set of polyketide synthases and reductase enzymes had been proposed to function in 
the biosynthetic pathways of gerberin, parasorboside and sporopollein. These enzymes 
are: 
Polyketide synthases: G2PS1, G2PS2, PKS8 
Reductase enzymes: GTKPR1, GRED1, GRED2 
The Lemo 21 constructs were revived from -80 °C deep freeze, cultured on LB (+50 
µg/ml kanamycin + 25 µg/ml chloramphenicol) plates and grown overnight. A single col-
ony from each plate culture was inoculated in 5 ml LB-broth (+kan +cam) in 15 ml plastic 
tubes and cultured for 5 h in 37 °C, 200 rpm to provide a starter culture. 
OD600 of the starter cultures were measured and the cultures were diluted sufficiently to 
reach an OD600 of 0.1 in two 25 ml cultures (50 ml in total per culture). These expression 
cultures were grown for 1 h to reach an OD600 of 0.2-0.6 after which they were combined 
to 50 ml volume in 250 ml flasks for protein induction. 
The expression cultures were induced with 20 µl 1 M IPTG (40 mM) to start protein ex-
pression. This was continued overnight in 16 °C (figure 6). The temperature was set to 
focus on protein production and inhibit cell division (propagation). Before adding IPTG, 
2 ml of the cultures were stored as control samples.  
After induction the culture tubes were centrifuged with 4000 rpm for 20 min to harvest 
the pellets. The pellets were resuspended in 1 ml LB and transferred to 1.5 ml centrifuge 
tubes, two for each pellet. The tubes were centrifuged again (5000 G, 10 min), the su-
pernatant was removed, and the pellets were weighted and stored in -20 °C.  
Control culture was a Lemo 21 strain with pHis8 vector without any insert in the mul-
ticloning site. 
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5.2 Protein Purification 
Purification was conducted according to the user manual provided with Ge Healthcare 
His SpinTrap kit (GE Healthcare product code 28932171) [15].  
For extraction of total proteins, the pellets were lysated in 4x volume (4x volume in ml to 
the weight of the pellet in mg) of extraction buffer (100 µg/ml lysozyme, 2.6 units Dnase 
(Thermo Scientific, 2600 unit/ml stock), 1x protease inhibitor. 10x inhibitor stock solution 
was made by dissolving a tablet in 1 ml B-PER reagent. B-PER reagent was used as 
solvent), incubated for 15 min and centrifuged at 15 000 G for 5 min. The column was 
prepared with binding buffer (10 mM imidazole, 1x phosphate buffer (from GE Healthcare 
Buffer Kit, product code 11003400) in H2O) by adding 600 µl of binding buffer and cen-
trifuging the column for 30 s at 100 G. After this the lysate supernatant solution was 
pipetted on the column and centrifuged for 30 s at 100 G. Before adding the lysate, 50 
µl of the solution was stored. This was called the total soluble protein fraction (TOTAL). 
Next the column was washed using 600 µl of binding buffer and finally the proteins were 
eluted twice using 200 µl of elution buffer (500 mM imidazole, 1x phosphate buffer in 
H2O) and centrifuging for 30 s at 100 G.  
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The following fractions were collected: 
• Total soluble protein, collected before purification, 50 µl (TOTAL) 
• Sample application flow through, volume depended on the volume of the lysate, 
200-400 µl (FLOW)  
• Washing flow through, 600 µl (WASH)  
• Elutions, 200 µl each (E1, E2) 
Of the pHis8 control sample, only the total soluble protein was collected. After purifica-
tion, protein concentration of the collected samples was measured with Bradford assay. 
In a 96-well plate 2 µl of the sample was diluted with 198 µl of water and mixed 20 times 
with 50 µl of dye reagent. Elution buffer from the purification stage was used as a blank 
sample. Samples that initially gave results above 0.6 were diluted sufficiently and meas-
ured again until the results were within range.  
5.3 Identification 
The expressed and purified protein were identified by their size and the presence of the 
histidine tag. 
5.3.1 SDS-PAGE 
SDS-PAGE analysis was performed to determine whether the produced enzymes were 
of correct size.  
A total of 10 µg of protein was pipetted in the SDS-gel wells. For each sample, the volume 
needed was calculated according to the concentration given by Bradford assay. The 
samples were denatured by adding 1/3 volume of SB denaturing reagent (100 mM Tris-
Cl, pH 6.9, 20 % glycerol, 4 % SDS, 10 % β-Mercapto EtOH, 0.2 mg/ml Bromophenol 
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blue) to the volume of sample. Denaturation was done by heating the sample for 5 min 
in 96 °C. The sample was pipetted into the gel wells and the gel was run for 35 min with 
200 V after which it was stained with PageBlue™ (Thermo Scientific, cat #24620) and 
washed with water. 
5.3.2 Bioluminecent Dot Blotting 
The method used in this work was based on a bioluminescence reaction that could be 
recorded on a film placed against a nitrocellulose membrane (Amersham Hybond-ECL, 
GE Healthcare, cat #RPN303D) in a closed film cassette. Depending on the quantity of 
his-tag sites in the sample (i.e. amount of target proteins) the more intense the lumines-
cence was. This corresponded to the size of a dot in the exposed film. 
Volumes of the sample solution corresponding to 5 µg of total protein was pipetted on 
the membrane. All fractions from the purification stage were included (total, flow, wash 
and elutions) for each enzyme. In addition, 2 µl of the pellets from the extraction step 
and 5 µl of the uninducted samples were included. 
After applying samples on the membrane, it was stained with Ponceau S by taking the 
following steps. All steps were done in room temperature and while shaking. 
Staining steps: 
1. The membrane was placed inside a plastic box with a lid 
2. Staining with 50 ml Ponceau S staining solution (0.1 % Ponceau S, 2.5 % glacial 
acetic acid in H2O) for 1 h. Afterwards the staining solution was poured back to 
the bottle. 
3. The membrane was rinsed with water until the background colour was gone  
4.  Most of the excess water was removed with a paper towel 
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Note that the staining was not a necessary step for dot blotting, and it was only used to 
get a visual interpretation of proteins on the membrane. 
Next the membrane was blotted according to Amersham ECL Prime Dot Blotting Detec-
tion Reagent instruction manual [17]: 
1. The membrane was washed with 50 ml tTBS buffer (20 mM Tris-Cl, 150 mM 
NaCl, 0.1% Tween® 20 (Sigma-Aldrich cat #P1379)) for 5 min 
2.  tTBS was poured off and 25 ml of blocking buffer (5 % non-fat dry milk powder 
(Valio cat #84062)) was added, and the membrane was shaken for 1 h 
3. Washing with 100 ml tTBS buffer for 10 min 
4. The membrane was rolled inside a 50 ml tube and the primary antibody solution 
(4 µl His-tag polyclonal antibody (Cell Signalling Technologies cat #2365S) in 20 
ml blocking buffer) was added. The tube was placed on a roller in +4 °C overnight. 
5. The membrane was rinsed and washed with tTBS three times for 10 min each. 
6. The secondary antibody (5 µl Anti-Rabbit IgG HRP-linked antibody (Cell Signal-
ling Technologies cat #7074P2) in 40 ml blocking buffer) was added on the mem-
brane for 1 h 
7. Washing four times with 100 ml tTBS for 10 min each. 
8. The membrane was dried with a paper towel and 1 ml Amersham ECL Dot Blot-
ting Detection Reagent™ (50:50 mix of ECL A and ECL B solutions (GE 
Healthcare cat #RPN2232)) was added and rolled on the membrane with a roller 
pin. 
9. The membrane was dried and placed inside a film cassette and the film was 
placed on top of it and the cassette was closed 
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10. Three exposures were made: 3 s, 2 min and 90 min. 
The film was removed from the cassette and submerged into a developing solution, 
washed with water and fixed with a fixing solution. Placing the film inside the box and 
treating it with developing and fixing solutions needed to be done in total darkness, be-
cause the film was too sensitive to have a red light on. 
6 Results 
6.1 Bradford Assay 
Bradford assay showed that the first elution had more protein than the second, as ex-
pected (Table 1). From the absorption value the protein concentration (C) was calcu-
lated, taking in to account the volume of sample in the wells and the dilution factors. For 
SDS-PAGE the volume that corresponded with 10 µg of protein was calculated from 
these results, taking to consideration the addition of 1/3 volume SB-solution. Bradford 
assays showed that the E. coli heterologous expression system works and produced a 
lot of protein, and some of the produced proteins could be purified by the his-tag purifi-
cation system  
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Table 1. Bradford assay tables. The total protein fraction volume is the amount of extraction buffer 
used (4x the weight of the pellet). This volume was pipetted on the purification column. Flowthrough 
volume is the volume after 50 µl of sample was removed. Note that 8*A595 is a factor in the method 
instructions. The 8x multiplication is derived from the calibration slope of the laboratory instructions. 
 
6.2 SDS-PAGE 
SDS-PAGE analysis showed that GRED1 and GRED2 had bands that were of different 
size than predicted. The predicted sizes of GRED1 and GRED2 are ~35 kDa but the 
strongest bands in the elution fraction were approximately 40-45 kDa according to SDS-
enzyme fraction volume of fraction (µl ) di lution factor A 595 8*A595 C (µg/µl ) protein (µg)
G2PS1 total  soluble protein 360 4 0.369 2.952 11.808 4250.9
1 µl  /wel l flowthrough 310 4 0.294 2.352 9.408 2916.5
wash 600 1 0.488 3.904 3.904 2342.4
elution 1 200 1 0.452 3.616 3.616 723.2
elution 2 200 1 0.181 1.448 1.448 289.6
G2PS2 total  soluble protein 288 4 0.283 2.264 9.056 2608.1
1 µl  /wel l flowthrough 238 4 0.133 1.064 4.256 1012.9
wash 600 1 0.327 2.616 2.616 1569.6
elution 2 200 1 0.112 0.896 0.896 179.2
elution 1 200 1 0.012 0.096 0.096 19.2
PKS8 total  soluble protein 336 4 0.42 3.36 13.440 4515.8
1 µl  /wel l flowthrough 286 4 0.403 3.224 12.896 3688.3
wash 600 1 0.407 3.256 13.024 7814.4
elution 1 200 1 0.141 1.128 1.128 225.6
elution 2 200 1 0.056 0.448 0.448 89.6
GTKPR1 total  soluble protein 323 8 0.559 4.472 17.888 5777.8
2 µl  /wel l flowthrough 273 8 0.245 1.96 7.840 2140.3
wash 600 1 0.622 4.976 2.488 1492.8
elution 1 200 1 0.416 3.328 1.664 332.8
elution 2 200 1 0.08 0.64 0.320 64.0
GRED1 total  soluble protein 258 8 0.548 4.384 17.536 4524.3
2 µl  /wel l flowthrough 208 8 0.146 1.168 4.672 971.8
wash 600 1 0.584 4.672 2.336 1401.6
elution 1 200 1 0.354 2.832 1.416 283.2
elution 2 200 1 0.196 1.568 0.784 156.8
GRED2 total  soluble protein 160 8 0.277 2.216 8.864 1418.2
2 µl  /wel l flowthrough 110 8 0.498 3.984 15.936 1753.0
wash 600 1 0.52 4.16 2.080 1248.0
elution 1 200 1 0.307 2.456 1.228 245.6
elution 2 200 1 0.131 1.048 0.524 104.8
Control total  soluble protein 232 1 0.336 2.688 10.752 2494.5
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PAGE. 35 kDa bands can be seen in the flow through (F) and wash (W) fractions. There 
was also a considerable band around 70 kDa (figure 5).  
G2PS1, G2PS2, PKS8 and GTKPR1 had bands in the elution fractions were of the pre-
dicted sizes (figure 6). They also seemed to purify more completely and did not show 
unspecific bands in the gel.  
Figure 6. SDS-PAGE analysis of G2PS1, G2PS2 and 
PKS8. GTKPR1 not shown. Only E1 fractions 
shown. 
Figure 5. SDS-PAGE analysis of GRED1 and GRED2. There are no bands of the predicted 
size in the elution fractions. The samples are: flowtrhough (F), wash (W), elutions (E1, 
E2). 10 µg of protein was pipetted on each well and 1/3 of that volume of SB denaturating 
reagent was added. 
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6.3 Dot Blot 
The Westen blot results showed that G2PS1, G2PS2, PKS8 and GTKPR1 had histidine-
tagged proteins in the elution fraction. Additionally, GTKPR1 had his-tagged proteins 
spread in all fractions. GRED1 and GRED2 did not have any considerable amounts of 
target proteins in the elution fraction, but instead a strong signal was detected in the 
pellet and in the total protein sample (figure 7). 
6.4 Modifications to Protocol 
A modification to the protocol was made in order to increase the amount of protein in the 
elution fraction. The modification was to remove imidazole from the binding buffer and 
re-applying the flow through three times to the purification column. The protocol was 
identical to previous procedures in all other aspects. This modification was performed 
with the enzyme GRED 1.  
Figure 7. Dot blot results. The numbers show the amount of sample (µl) 
pipetted on the membrane that corresponded to 10 µg of protein. Image 
is from a film exposed for 3 hrs. 
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Table 2. Bradford assay results of purification fractiong of GRED1. The amount of protein increased 
from the previous purification of GRED1 from 283,2 to 361,6 µg in the first elution for example. 
 
Bradford assay results showed that both the concentration and total amount of enzyme 
increased (table 2) in both elution fractions. The increase of protein increased by 51.54 
% from the first purification when calculating with the combined amounts of both elutions: 
(362.6 µ𝑔+304.8 µ𝑔)−(283.2 µ𝑔+156.8 µ𝑔)
(283.2 µ𝑔+156.8 µ𝑔)
∗ 100 = 51.45 %   (1) 
7 Discussion 
Working with proteins always requires good planning and scheduling and results may 
vary even with the most careful work.  
All the enzymes were expressed with the heterologous expression method as the his-
tag signal was detected in all of the total protein samples. It seems that GRED1 and 
GRED2 did not express as hoped. According to SDS-PAGE and dot blot the target pro-
teins remained in the pellet fraction and were possibly of different size than predicted. 
One possibility is that the proteins dimerizied and produced a band on 70 kDa given that 
GRED1 and GRED2 were of 35 kDa size and a dimer would therefore be around 70 kDa. 
It was discussed that Lemo 21 might not be the optimal expression host for recombinant 
reductases and Rosetta-strain was proposed as a replacement for future experiments. 
The rest of the proteins were successfully purified and were identified in the expected 
manner. GTKPR1 had histidine tagged protein in all fractions but still the elution fraction 
produced a strong signal in dot blotting. 
Reductase enzymes are known to be difficult to express and purify. It was speculated 
that the reductases may not fold correctly during the expression or they denaturized 
quickly after. The strong signal in the pellet fraction in dot blot also suggests that the 
enzyme fraction di lution factor A 595 8*A595 C V1 (10 µg/C) V2 (4/3*V1)
GRED1 total  soluble protein 8 0.548 4.384 17.536 0.570 0.760
flowthrough 8 0.146 1.168 4.672 2.140 2.854
wash 1 0.584 4.672 2.336 4.281 5.708
elution 1 1 0.354 2.832 1.416 7.062 9.416
elution 2 1 0.196 1.568 0.784 12.755 17.007
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reductases did not solve into the lysate buffer completely. The his-tag might be folded 
inside the protein structure, which makes the purification and identification of the protein 
impossible. It is also possible that the enzymes lose activity during the extraction and 
purification stages because of an incorrect folding. In addition, finding the isoelectronic 
point (PI) of the reductases and checking the pH value of the lysate buffer is advisable. 
This would make it possible to adjust the pH of the buffer so that the enzymes would 
solve. The expression and purification protocols were modified in order to increase yield 
and the final concentration of the enzyme. An enzymatic assay was also attempted with 
GTKPR1, ATKPR1 and ATKPR2 (A. thaliana reductases) but the enzymes showed no 
activity. 
Even though the yield of GRED1 increased considerably, the signal produced remained 
relatively weak compared to other enzymes. Steps should be taken in order to express 
the enzymes and retain the natural form. In the future, a different protocol for the expres-
sion and purification of the reductases is needed in order to properly study the biosyn-
thetic pathways of gerberin and parasorboside. Also, modifications to existing protocols 
should be explored further and repeated to obtain reliable data on their effect on the 
yield. 
The study of this pathway and related genes could result in significant applications in 
farming economically important plants, for example producing mould-resistant strawber-
ries.  
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Appendix 1: Reagents 
Protein expression
Reagent Manufacturer C CAS # Lot # notes
LB-broth internal - - - autoclaved
LB-agar internal - - - autoclaved
Kanamycin Sigma-Aldrich solid 25389-94-0 SLBR6873V store at - 20 °C
Chloramphenicol Duchefa Biochemie solid 56-75-7 009104.03 store at - 20 °C
IPTG Sigma-Aldrich solid 367-93-1 store at +4 ° C
(Isopropyl-beta-D-thiogalactopyranoside)
Protein Extraction and purification
Reagent Manufacturer C CAS # Lot # notes
Bacterial Protein Extraction Reagent (B-PER™) Thermo Scientific - - TK274478 -
Lysozyme Sigma-Aldrich solid 9001-63-2 57H7045 store at - 20 °C
Dnase Thermo Scientific 2616 U/ml 9003-98-9 TI270908 store at - 20 °C
Imidazole GE Healthcate 2 M 288-32-4 10222985 store at +4 ° C
Phosphate buffer GE Healthcate 8x stock - 10222984 store at +4 °C
Protein Assay Dye Reagent Concentrate Bio-Rad - - - store at +4 °C
Protease inhibitor tablets Roche solid - 38591400 store at +4 °C
 dissolve 1 tablet in 1 ml H2O for 10x stock
SDS-PAGE
Reagent Manufacturer C CAS # Lot # notes
Tris Base Fisher BioReagents solid 77-86-1 178204
Glycine Fisher Chemical solid 56-40-6 1869865 -
SDS Fluka solid 151-21-3 409773/1
SB solution internal 4x stock - - store at -20 °C
PageBlue™ Protein staining solution Thermo Scientific - 67-63-0 725515
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Western blot
Reagent Manufacturer C CAS # Lot # notes
TWEEN®20 Sigma-Aldrich - 9005-64-5 SLBV0519 highly viscous, cut the pipette tip
Acetic acid Sigma-Aldrich ≥ 99,8 % 64-19-7 SZBD1910V
Ponceau S Hoechst solid 6226-79-5 49097 can be reused
TRIS-HCl internal 1 M 1185-53-1 - autoclaved, pH 8
NaCl internal 5 M 7647-14-5 - autoclaved
Skimmed milk powder Valio solid - 7,096E+10 -
His-Tag Polyclonal antibody Cell Signaling Technology- - 3 store at - 20 °C
Anti-rabbit IgG, HRP-linked antibody Cell Signaling Technology- - 28 store at - 20 °C
Amersham™ ECL ™ Solutions A and B Ge Healthcare - - 16919972 -
Metabolite extraction and analysis
Reagent Manufacturer C CAS # Lot # notes
Liquid nitrogen AGA ≥ 99,8 % 7727-37-9 - -195 °C
Methanol Fisher Chemical ≥ 99,8 % 67-56-1 1995520
Methanol (HPLC grade) Fisher Chemical 99,99 % 67-56-1 1400549
Dicholomethane Fluka Analytical ≥ 99,9 % 75-09-2 SZBA1090
Ethyl acetate Sigma-Aldrich ≥ 99-7 % 141-78-6 SZBD296AV
Formic acid Fisher Chemical ≥ 98 % 64-18-6 1883935
Acetic acid Sigma-Aldrich ≥ 99,8 % 64-19-7 SZBD1910V
Sulphuric acid Sigma-Aldrich 18,4 M 7664-93-9 STBG6249
Na-acetate internal 0,1 M - - pH 5
β-Glucosidase Sigma-Aldrich 2,25 U/mg solid 9001-22-3 108K4119 store at +4 °C
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Appendix 2: Buffers and solutions 
 
 
 
Extraction and purification
Extraction buffer, 1 ml
B-PER 888 µl
lysozyme 10 µl
Dnase 2 µl
10x inhibitor stock 100 µl
total 1000 µl
Binding buffer, 1 ml
8x Phosphate 125 µl
2 M imidazole 5 µl
H2O 870 µl
total 1000 µl
Elution buffer, 1ml
8x phosphate 125 µl
2 M imidazole 250 µl
H2O 625 µl
total 1000 µl
SDS
Running buffer, 10x stock, 1 l
Tris Base 30,3 g
Clycine 144,1 g
SDS 10 g
H2O 1000 ml
SB solution, 4x stock, 25 ml
Tris-HCl 2,5 mM
clycerol 5,8 ml
SDS 1 g
β-Mercapto EtOH 2,5 ml
Bromophenol blue 5 mg
H2O fill to 25 ml
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Western blot
tTBS buffer, 1 l
Tris-HCl 20 ml
NaCl 30 ml
TWEEN® 20 1 ml
H2O fill to 1000 ml
5 % Blocking buffer, 50 ml
Milk powder 1 g
TBS buffer 50 ml
note: Mix with magnetic stirrer for 30 min
Poinceau S staining solution, 200 ml
Poinceau S 0,2 g
Acetic acid (glacial) 5 ml
H2O fill to 200 ml
Primary antibody
His-Tag polyclonal a.b. 4 µl
5 % Blocking buffer 20 ml
Secondary antibody
Anti-rabbit IgG HRP-linked a.b. 5 µl
5 % Blocking buffer 40 ml
TLC-analysis
Running buffer A
MeOH 7,5 ml
Dicholomethane 42,5 ml
total 50 ml
Running buffer B
Ethyl acetate 34 ml
Formic acid 3,75 ml
acetic acid 3,75 ml
H2O 8,5 ml
total 50 ml
